Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the schedule hereto:
Schedule
Product: Abelcet
Active Ingredient(s): Amphotericin B 5mg/mL
Dosage Form: Emulsion for infusion
New Zealand Sponsor: Amgen New Zealand Branch Amgen Australia Pty Limited
Manufacturer(s): The Liposome Company Inc, Indianapolis, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Hemohes
Active Ingredient(s): Pentastarch 10%w/v
Dosage Form: Solution for injection
New Zealand Sponsor: Biomed Limited
Manufacturer(s): Biomed Limited, Pt Chevalier, Auckland
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Pentaspan
Active Ingredient(s): Pentastarch 100mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boots Healthcare Medical N Z Div. Boots Healthcare Australia
Manufacturer(s): NPBI BV, Runde, Emmer-Compascuum, The Netherlands
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 15th day of April 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).